Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

2719 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Lampalizumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5622-50mg

IchorBio
50 mg Login
Compare
Lampalizumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5622-5mg

IchorBio
5 mg Login
Compare
Laprituximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5626-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Laprituximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5626-1mg

IchorBio
1 mg Login
Compare
Laprituximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5626-25mg

IchorBio
25 mg Login
Compare
Laprituximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5626-50mg

IchorBio
50 mg Login
Compare
Laprituximab Biosimilar -­ Research Grade Hu FA CHO cells ICH5626-5mg

IchorBio
5 mg Login
Compare
Laprituximab Emtansine Biosimilar -­ Research Grade Hu FA CHO cells ICH5626E-0.1mg

IchorBio
0.1 mg Login
Compare
Laprituximab Emtansine Biosimilar -­ Research Grade Hu FA CHO cells ICH5626E-1mg

IchorBio
1 mg Login
Compare
Leronlimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5634-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Leronlimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5634-1mg

IchorBio
1 mg Login
Compare
Leronlimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5634-25mg

IchorBio
25 mg Login
Compare
Leronlimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5634-50mg

IchorBio
50 mg Login
Compare
Leronlimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5634-5mg

IchorBio
5 mg Login
Compare
Levilimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5639-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Levilimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5639-1mg

IchorBio
1 mg Login
Compare
Levilimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5639-25mg

IchorBio
25 mg Login
Compare
Levilimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5639-50mg

IchorBio
50 mg Login
Compare
Levilimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5639-5mg

IchorBio
5 mg Login
Compare
Licaminlimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5643-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Licaminlimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5643-1mg

IchorBio
1 mg Login
Compare
Licaminlimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5643-25mg

IchorBio
25 mg Login
Compare
Licaminlimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5643-50mg

IchorBio
50 mg Login
Compare
Licaminlimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5643-5mg

IchorBio
5 mg Login
Compare
Lilotomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5645-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Name Price
Lampalizumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Lampalizumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Laprituximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Laprituximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Laprituximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Laprituximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Laprituximab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Laprituximab Emtansine Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 0.1 mg
Available
Laprituximab Emtansine Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Leronlimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Leronlimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Leronlimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Leronlimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Leronlimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Levilimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Levilimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Levilimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Levilimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Levilimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Licaminlimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Licaminlimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Licaminlimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Licaminlimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Licaminlimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Lilotomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available

2719 Item(s)

per page